Professor Stan Gronthos
Professor
School of Biomedicine
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Prof. Stan Gronthos' research specialty is in stem cell biology and regenerative medicine. He is Founder and Head of the Mesenchymal Stem Cell Laboratory in the Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide. In 2018, Prof Gronthos was awarded a Fellow of the American Society of Bone and Mineral Research. In 2014, the Mesenchymal Stem Cell Laboratory moved to the South Australian Health and Medical Research Institute (SAHMRI) on North Terrace, adjacent to the new Royal Adelaide Hospital site.
Research Interests
The focus of the Mesenchymal Stem Cell Laboratory is to investigate the origin and biological properties of different postnatal mesenchymal stem cell (MSC) populations, that give rise to supportive connective tissues such as myelosupportive stroma, adipose tissue, smooth muscle, cardiac muscle, bone, cartilage, ligament, cementum and dentin. Our work seeks to identify critical genes and epigenetic factors that regulate MSC self-renewal, proliferation and differentiation. In addition, research efforts have focused on identifying the factors central to MSC mediated regulation of haematopiesis, angiogenesis and immune cell modulation. Importantly, many of these molecular processes are considered underlying causes of chronic diseases and tumour cell development. Together with Prof. Andrew Zannettino and our commercial partner (Mesoblast Ltd), our basic research activities have progressed into Phase II/III human clinical trails for orthopaedic, cardiovascular, cancer and immune based indications. Our continuing research into the basic properties of MSC will help develop more effective and safer stem cell based therapeutic options in the future for a wide variety of clinical diseases and conditions.
PATENTS:
- Inventors: Gronthos S., Zannettino A.C.W., Simmons P.J., Patent: Mesenchymal Precursor Cells WO2001/04268A1. Applicant: Medvet Science Pty Ltd, Adelaide, S.A., Australia. 1999, licensed to Angioblast Systems Inc., New York, NY. Granted in USA, AUS, CA, ES, EP.
- Inventors: Gronthos S., Robey P.G., Miura M., and Shi S. Postnatal stem cells and uses thereof. U.S. Patent Application No. PCT/US2003/012276. WO2004/094588A2. Applicant: National Institutes of Health, Bethesda, Maryland USA. Granted in the USA, EP, ES, CA.
- Inventors: Gronthos S., Robey P.G., and Shi S. U.S. "Adult human dental pulp stem cells In Vitro and In Vivo". Provisional Patent Application No. 60/219,989, WO2002/007679A2. Applicant: National Institutes of Health, Bethesda, Maryland, USA. Granted in the USA, AUS, CA, ES, EP.
- Inventors: Stan Gronthos, Songtao Shi and Andrew Zannettino. Perivascular Mesenchymal Precursor Cells. Provisional application PCT/AU2004/000416, WO2004/085630A1. Applicants: Medvet Science Pty Ltd, Adelaide, S.A., Australia and Angioblast Inc. New York, NY. Granted in USA, AUS, CA, CN.
- Inventors: Stan Gronthos and Andrew Zannettino Perivascular Mesenchymal Precursor Cell Induced Blood Vessel Formation (Neovascularization) 28-Mar-2003 Provisional application PCT Application No PCT/AU2004/000417, WO2004/084921A1, Medvet Science Pty Ltd, Adelaide, S.A., Australia and Angioblast Inc. Granted in USA, AUS, EP, CA, CN, ES.
- Inventors: Stan Gronthos and Andrew Zannettino. Multipotential expanded Mesenchymal Precursor Cell progeny and uses there off. PCT/AU2005/001445, 24/09/2004, WO2006/032092A1. Applicant: Angioblast Systems Inc. New York, NY. Granted in US, AU, EP, CN.
- Inventors: Stan Gronthos, Andrew Zannettino, Paul Simmons. Isolation of adult multipotential Cells by tissue non-specific alkaline phosphotase. PCT/AU2006/000494; W02006/108229A1. Applicant: Angioblast Systems Inc. New York, NY. Granted in USA, AU, EP, CA, HK.
- Inventors: Stan Gronthos and Andrew Zannettino. Method of enhancing proliferation and/or survival of mesenchymal precursor cells. PCT/AU2005/000953, WO2006/032075A1. Applicant: Angioblast Systems Inc. New York, NY. Granted in the USA, AUS, CN.
- Inventors: Gronthos S, Koblar SA, Arthur A. International (PCT) Patent Application (PCT/AU2008/001286; WO2009/026653A8) “Neuroplasticity Assay”. Applicant: MedVet/ Science Pty. Ltd/ Adelaide Research & Innovation Pty. Ltd.
- Inventors: Stan Gronthos and Andrew Zannettino. Monoclonal antibody STRO-4 (Provisional; US 61/189,349) 18/08/2008; PCT WO2010/019997A1. Applicant: Angioblast Systems Inc. New York, NY. Granted in AUS, USA.
- Inventors: Gronthos S, Koblar SA, Arthur A. Patent Application WO2012/162758A1, US201161493057P filed on 3 June 2011 entitled “Method Of Treating The Effects Of Stroke”; Applicant Mesoblast Pty Ltd. Granted in AUS.
- Inventors: Gronthos S, Zannettino ACW and Fitter S. AUS Provisional Patent # 2015902032 filed on 1 June 2015; PCT/AU2016/050438; entitled “Methods and Products for Enriching and Isolating Stem Cell”; Applicant: Adelaide Research & Innovation Pty. Ltd.
Research Projects Available
Mesenchymal Stem Cell Laboratory, AMS, Medical Sciences
Lab Head, Prof Stan Gronthos
Postnatal mesenchymal stem cells (MSC) derived from connective tissues are capable of developing into multiple cell lineages (myelosupportive stroma, adipocytes, smooth muscle cells, myoblasts, ligament cells, chondrocytes and osteoblasts). Our Lab examines the transcriptional, epigenetic and signalling factors that regulate MSC self-renewal, proliferation, multi-differentiation and immune cell modulation. These molecular processes are being investigated as underlying mechanisms mediating tissue repair, inflammation, tumour cell development and aged related diseases.
http://www.adelaide.edu.au/directory/stan.gronthos
https://researchers.adelaide.edu.au/profile/stan.gronthos
Location: Level 5 South SAHMRI
Research project start: Semester 1 and 2 for Hons and Third year placements
Special requirements: HepB vaccination required
Projects for 2020
1. Pharmacological targeting of tyrosine kinase receptors and epigenetic modifying enzymes in mesenchymal stem cells to treat cranial bone conditions. (The use of chemical inhibitors to modify bone cell differentiation by mesenchymal stem cells in the cranial sutures to treat craniosynostosis in children).
2. Investigation of the importance of cell-cell communication and cross-talk between bone cells, blood cells and neural cells during skeletal development/ repair. (Investigating the role of the membrane bound contact dependent molecules, Eph/ ephrin, to mediate cell-cell communication and function between bone cells, blood/ immune cells and neural tissue, during development and tissue repair).
3. Investigating the role of epigenetic modifiers to control mesenchymal stem cell self-renewal and cell fate determination in development and tissue repair. (Investigation of the role of histone acetylation and methylation or DNA methylation in mesenchymal stem cell self-renewal and cell fate determination, in the context of skeletal stem cell ageing and bone disease).
HDR Projects
1. Pharmacological targeting of tyrosine kinase receptors and epigenetic modifying enzymes in mesenchymal stem cells to treat cranial bone conditions.
2. Investigation of the importance of cell-cell communication and cross-talk between bone cells, blood cells and neural cells during skeletal development/ repair.
6. Histone acetylation and methylation as regulators of mesenchymal stem cell self-renewal and cell fate determination.
5. Examining the role of DNA methylation in skeletal stem cell ageing and bone disease.
Hons and Third year placements (Semester 1 and 2 ) Projects
1. Identification of molecular mechanisms controlling cranial bone development in children.
2. Investigating mechanisms of cell-cell communication during tooth formation.
3. Investigation mechanisms of cell-cell communication in bone and cartilage development.
4. Identifying Epigenetic Enzymes involved in the growth and differentiation of bone marrow derived mesenchymal stem cells.
5. Identifying Epigenetic "Readers" involved in mesenchymal stem cell growth and
differentiation.
-
Appointments
Date Position Institution name 2012 - ongoing Professor in Stem Cell Biology and Regenerative Medicine University of Adelaide -
Education
Date Institution name Country Title 1994 - 1988 University of Adelaide Australia PhD -
Postgraduate Training
Date Title Institution Country 1999 - 2001 NIH Research Fellow National Institutes of Health United States -
Research Interests
-
Journals
-
Book Chapters
Year Citation 2019 Gronthos, S. (2019). Features of mesenchymal stem cells. In X. -D. Chen (Ed.), A Roadmap to Nonhematopoietic Stem Cell-Based Therapeutics: From the Bench to the Clinic (pp. 15-38). London, United Kingdom: Academic Press.
DOI Scopus22017 Mrozik, K., Gronthos, S., Shi, S., & Bartold, P. M. (2017). A method to isolate, purify, and characterize human periodontal ligament stem cells. In Methods in Molecular Biology (Vol. 1537, pp. 413-427). Springer New York.
DOI Scopus32 Europe PMC152017 Ivanovski, S., Mark Bartold, P., Gronthos, S., & Hutmacher, D. (2017). Periodontal tissue engineering. In R. Waddington, & A. Sloan (Eds.), Tissue Engineering and Regeneration in Dentistry: Current Strategies (pp. 124-144). Chichester, West Sussex; UK: Wiley & Sons.
DOI Scopus22017 Hemming, S., & Cakouros, D. (2017). Epigenetic regulation of mesenchymal stem/stromal cell growth and multipotentiality. In K. Atkinson (Ed.), The Biology and Therapeutic Application of Mesenchymal Cells (pp. 41-57). Hoboken, New Jersey: John Wiley and Sons. 2017 Arthur, A., Shi, S., & Gronthos, S. (2017). Dental Pulp Stem Cells: What’s New?. In M. Tatullo (Ed.), MSCs and Innovative Biomaterials in Dentistry (pp. 1-20). Springer.
DOI2015 Menicanin, D., Hynes, K., Han, J., Gronthos, S., & Bartold, P. (2015). Cementum and periodontal ligament regeneration. In L. Bertassoni, & P. Coelho (Eds.), Engineering Mineralized and Load Bearing Tissues (Vol. 881, pp. 207-236). Switzerland: Springer.
DOI Scopus31 WoS20 Europe PMC162014 Arthur, A., Shi, S., & Gronthos, S. (2014). Dental Pulp Stem Cells. In A. Vishwakarma, P. Sharpe, S. Shi, & M. Ramalingam (Eds.), Stem Cell Biology and Tissue Engineering in Dental Sciences (pp. 279-289). United Kingdom: Elsevier Science Publishing Co Inc.
DOI Scopus52013 Arthur, A., Zannettino, A., & Gronthos, S. (2013). The multipotential of Mesenchymal / Stromal Stem Cells in Skeletal Tissue Repair.. In R. Rajendram, V. Preedy, & V. Patel (Eds.), Stem Cells and Bone Tissue (pp. 82-102).
DOI Scopus32013 Wang, L., Morsczeck, C., Gronthos, S., & Shi, S. (2013). Regulation and differentiation potential of dental mesenchymal stem cells. In G. Huang, & I. Thesleff (Eds.), Stem cells in craniofacial development and regeneration (pp. 303-314). United Kingdom: John Wiley & Sons.
DOI Scopus32013 Shi, S., & Gronthos, S. (2013). Bone marrow mesenchymal stem cells. In G. Huang, & I. Thesleff (Eds.), Stem cells in craniofacial development and regeneration (pp. 223-239). United States: John Wiley & Sons.
DOI Scopus32012 Mrozik, K., Xiong, J., Zilm, P., Gronthos, S., & Bartold, P. (2012). Proteomic Characterization of Mesenchymal Stem Cell-Like Populations Derived from Various Tissue Types. In M. Hayat (Ed.), Stem cells and cancer stem cells: Therapeutic applications in disease and injury. Volume 3 (pp. 75-94). New York: Springer.
DOI2012 Akiyama, K., Chen, C., Gronthos, S., & Shi, S. (2012). Lineage differentiation of mesenchymal stem cells from dental pulp, apical papilla, and periodontal ligament. In C. Kioussi (Ed.), Odontogenesis: methods and protocols (Vol. ., pp. 111-121). Humana Press.
DOI Scopus37 Europe PMC242012 Mrozik, K., Xiong, J., Zilm, P., Gronthos, S., & Bartold, P. (2012). Proteomic characterization of mesenchymal stem cell-like populations derived from various tissue types. In M. Hayat (Ed.), Stem cells and cancer stem cells: Therapeutic applications in disease and injury. Volume 4 (pp. 267-284). Springer.
DOI2012 Akiyama, K., Chen, C., Gronthos, S., & Shi, S. (2012). Lineage Differentiation of Mesenchymal Stem Cells from Dental Pulp, Apical Papilla, and Periodontal Ligament. In Methods in Molecular Biology (pp. 111-121). Humana Press.
DOI2011 Gronthos, S., & Zannettino, A. (2011). Methods for the purification and characterization of human adipose-derived stem cells.. In J. Gimble, & B. Bunnell (Eds.), Methods in Molecular Biology: Adipose-Derived Stem Cells - Methods and Protocols (Vol. 702, 1 ed., pp. 109-120). USA: Humana Press.
DOI Scopus20 Europe PMC142010 Mrozik, K., Gronthos, S., Shi, S., & Bartold, P. (2010). A method to isolate, purify, and characterize human periodontal ligament stem cells. In G. Seymour, M. Cullinan, & N. Heng (Eds.), Oral Biology: Molecular Techniques and Applications (Vol. 666, 1 ed., pp. 269-284). USA: Humana Press.
DOI Scopus44 Europe PMC332008 Gronthos, S., & Zannettino, A. (2008). A method to isolate and purify human bone marrow stromal stem cells. In D. Prockop, D. Phinney, & B. Bunnell (Eds.), Mesenchymal Stem Cells: Methods and Protocols (Vol. 449, pp. 45-57). United States: Humana Press.
DOI Scopus53 Europe PMC322008 Gronthos, S., & Zannettino, A. (2008). Potential of Bone Marrow Stromal Stem Cells to Repair Bone Defects and Fractures. In P. Koka (Ed.), Progress in Stem Cell Research (pp. 47-62). New York: Nova Science Publishers. 2008 Zannettino, A., Martin, S. K., Gronthos, S., To, L., & Peet, D. (2008). The role of CXCL12 in multiple myeloma. In F. columbus (Ed.), Cancer Research Progress. Nova Science Publishers. 2007 Sonoyama, W., Yamaza, T., Gronthos, S., & Shi, S. (2007). Multipotent Stem Cells in Dental Pulp. In Culture of Human Stem Cells (pp. 187-206). Wiley.
DOI Scopus111998 Gronthos, S., Graves, S., & Simmons, P. (1998). Isolation, purification and in vitro manipulation of human bone marrow stromal precursor cells. In Marrow stromal cell culture, 1998 (pp. 26-42). Cambridge University Press. -
Conference Papers
Year Citation 2021 Kutyna, M., Kok, C. H., Wee, L. Y., Paton, S., Chhetri, R., Thomas, D., . . . Hiwase, D. (2021). BONE MARROW MICROENVIRONMENT IN THERAPY-RELATED MYELOID NEOPLASMS IS DISTINCT FROM OTHER MYELOID NEOPLASMS, PROBABLY DRIVEN BY PRIOR CYTOTOXIC THERAPY. In LEUKEMIA RESEARCH Vol. 108 (pp. S18-S19). PERGAMON-ELSEVIER SCIENCE LTD. 2021 Kutyna, M. M., Kok, C. H., Paton, S., Cakouros, D., Arthur, A., Hughes, T. P., . . . Hiwase, D. (2021). Distinct Senescent Bone Marrow Microenvironment in Therapy-Related Myeloid Neoplasms. In BLOOD Vol. 138 (pp. 4 pages). Atlanta, GA: AMER SOC HEMATOLOGY.
DOI WoS12020 Campbell, J. M., Habibalahi, A., Mahbub, S., Paton, S., Gronthos, S., & Goldys, E. (2020). Multispectral characterisation of mesenchymal stem/stromal cells: Age, cell cycle, senescence, and pluripotency. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE Vol. 11251 (pp. 1-7). online: SPIE.
DOI Scopus3 WoS12019 Arthur, A., Paton, S., Gronthos, S., & Zannettino, A. (2019). The Loss of ephrinB1 in Osteoprogenitors Delays Fracture Repair. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 34 (pp. 326). Orlando, FL: WILEY. 2019 Kutyna, M., Paton, S., Gronthos, S., & Hiwase, D. (2019). ABERRANT BONE MARROW MICROENVIRONMENT IN THERAPY RELATED MYELOID NEOPLASM. In EXPERIMENTAL HEMATOLOGY Vol. 76 (pp. E3-E4). ELSEVIER SCIENCE INC. 2018 Camp, E., Anderson, P., Zannettino, A., & Gronthos, S. (2018). Inhibition of tyrosine kinase receptor C-ROS-1 as a novel treatment for patients with TWIST haploinsufficiency induced craniosynostosis. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 33 (pp. 424). Montreal, CANADA: WILEY. 2018 Nguyen, T. M., Arthur, A., & Gronthos, S. (2018). EPHA FORWARD SIGNALLINGS ENHANCE HUMAN HAEMATOPOIETIC PROGENITOR CELL MIGRATION AND ADHESION VIA RAC1 ACTIVATION. In JOURNAL OF GENE MEDICINE Vol. 20 (pp. 1 page). Univ Technol Sydney, Sydney, AUSTRALIA: WILEY. 2017 Zeissig, M. N., Hewett, D. R., Martin, S., Mrozik, K. M., Cheong, C. M., Diamond, P., . . . Zannettino, A. C. W. (2017). HIF-2α Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma. In BLOOD Vol. 130 (pp. 2 pages). Atlanta, GA: AMER SOC HEMATOLOGY. 2016 Sivanathan, K., Rojas-Canales, D., Gronthos, S., Grey, S., & Coates, P. T. (2016). Supercharging mesenchymal stem cells with Interleukin-17A: An alternative to interferon-gamma enhancement of mesenchymal stem cell immunomodulation. In TRANSPLANTATION Vol. 100 (pp. S68-S69). LIPPINCOTT WILLIAMS & WILKINS. 2016 Sivanathan, K., Rojas-Canales, D., Gronthos, S., Grey, S., & Coates, P. T. (2016). Immunodepletion and hypoxia preconditioning of mouse compact bone cells as a novel protocol to isolate highly immunosuppressive mesenchymal stem cells. In TRANSPLANTATION Vol. 100 (pp. S494). LIPPINCOTT WILLIAMS & WILKINS. 2016 Nguyen, T., Arthur, A., Purton, L., Hayball, J., Zannettino, A., Paton, S., . . . Gronthos, S. (2016). EphB4 enhances bone marrow stromal stem cell-mediated support of haematopoiesis. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 173 (pp. 30). British Soc Haematol, Glasgow, SCOTLAND: WILEY-BLACKWELL. 2016 Nguyen, T. M., Arthur, A., Paton, S., Purton, L. E., & Gronthos, S. (2016). EphrinB1 expressing stromal cells exhibit an enhanced capacity for haematopoietic stem cell maintenance. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 173 (pp. 30). British Soc Haematol, Glasgow, SCOTLAND: WILEY-BLACKWELL. 2016 Ebert, L., Tan, L. Y., Min, K. K. M., Cockshell, M., Johan, M. Z., Parham, K., . . . Bonder, C. (2016). Desmoglein 2 (DSG2) is a novel surface marker of endothelial and haematopoietic progenitor cells, and plays a critical role in neoangiogenesis. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 309). Melbourne, AUSTRALIA: WILEY-BLACKWELL. 2015 Sivanathan, K., Rojas-Canales, D., Hope, C., Gronthos, S., Grey, S., & Coates, P. T. (2015). GENE MICROARRAY COMPARATIVE ANALYSIS OF INTERFERON-GAMMA AND INTERLEUKIN-17A PRECONDITIONED HUMAN MESENCHYMAL STEM CELLS.. In TRANSPLANTATION Vol. 99 (pp. S39-S40). Melbourne, AUSTRALIA: LIPPINCOTT WILLIAMS & WILKINS. 2015 Sivanathan, K., Rojas-Canales, D., Gronthos, S., Grey, S., & Coates, P. T. (2015). MICROARRAY GENE PROFILE STUDY OF IMMUNOSUPPRESSIVE INTERLEUKIN-17A PREACTIVATED HUMAN MESENCHYMAL STEM CELLS.. In TRANSPLANTATION Vol. 99 (pp. S48). Lorne, AUSTRALIA: LIPPINCOTT WILLIAMS & WILKINS. 2015 Sivanathan, K., Rojas-Canales, D., Grey, S., Hope, C., Carroll, R., Gronthos, S., & Coates, P. (2015). Interleukin-17A Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function. In AMERICAN JOURNAL OF TRANSPLANTATION Vol. 15 (pp. 1 page). Philadelphia, PA: WILEY-BLACKWELL. 2015 Jackson, M. R., Roberts, A. L. K. D., Gronthos, S., & Byers, S. (2015). IDURONIDASE TRANSDUCED MSCS IMPROVE THE BEHAVIOURAL DEFICITS IN MUCOPOLYSACCHARIDOSIS I MICE WITH LIMITED BIOCHEMICAL CORRECTIONS. In JOURNAL OF GENE MEDICINE Vol. 17 (pp. 197-198). Univ Melbourne, Univ Coll, Parkville, AUSTRALIA: WILEY-BLACKWELL. 2015 Sivanathan, K., Canales, D. R., Hope, C., Gronthos, S., Grey, S., & Coates, P. T. (2015). Gene microarray comparative analysis of interferon-gamma and interleukin-17a preconditioned human mesenchymal stem cells. In XENOTRANSPLANTATION Vol. 22 (pp. S25). Melbourne, AUSTRALIA: WILEY-BLACKWELL. 2015 Jackson, M. R., Robertsa, A. L. K. D., Gronthos, S., & Byers, S. (2015). α-l-Iduronidase transduced mesenchymal stem cells improve the behavioral deficits in mucopolysaccharidosis type I mice. In Abstracts Molecular Genetics and Metabolism Vol. 114 (pp. S58). Orlando, FL: Elsevier.
DOI2013 Noll, J., Williams, S., Tong, C., Wang, H., Purton, L., Farrugia, A., . . . Zannettino, A. (2013). MYELOMA PLASMA CELLS ALTER THE BONE MICROENVIRONMENT BY STIMULATING AN INCREASE IN MESENCHYMAL STEM CELLS: A COMPARATIVE STUDY OF MYELOMA PATIENT- AND MURINE MODEL-DERIVED MESENCHYME. In HAEMATOLOGICA Vol. 98 (pp. 95). FERRATA STORTI FOUNDATION. 2011 Arthur, A., Panagopoulos, R., Cooper, L., Zannettino, A., Koblar, S. A., Sims, N. A., . . . Gronthos, S. (2011). THE ROLE OF EPHB/EPHRINB MOLECULES IN FRACTURE REPAIR. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S523). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD. 2009 Arthur, A., Stylianou, C., Koblar, S. A., Matsuo, K., & Gronthos, S. (2009). EphB/ephrin-B interactions assist in MSC niche maintenance and contribute to bone remodelling following injury. In BONE Vol. 44 (pp. S142-S143). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI2009 Gronthos, S., Isenmann, S., Arthur, A., Zannettino, A. C. W., Shi, S., & Glackin, C. A. (2009). The role of Twist-1 and-2 in the maintenance of mesenchymal stromal/stem cells. In BONE Vol. 44 (pp. S146). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI2009 Psaltis, P. J., Carbone, A., Manavis, J., Jantzen, T., Lau, D., Sanders, P., . . . Worthley, S. G. (2009). Catheter-based Electromechanical Mapping Accurately Characterizes Segmental Distribution of Left Ventricular Fibrosis in Nonischemic Cardiomyopathy. In CIRCULATION Vol. 120 (pp. S906). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. 2009 Psaltis, P. J., Zannettino, A., Carbone, A., Manavis, J., Williams, K., Jantzen, T., . . . Worthley, S. G. (2009). Cardiac Repair With Transendocardial Injection of Allogeneic Mesenchymal Precursor Cells for Nonischemic Cardiomyopathy. In CIRCULATION Vol. 120 (pp. S827). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. 2009 Psaltis, P. J., Worthley, S. G., See, F., Itescu, S., Martens, T., Gronthos, S., & Zannettino, A. (2009). Enrichment for Stro-1 Enhances Paracine-mediated Cardiovascular Repair From Human Bone Marrow Mesenchymal Cells. In CIRCULATION Vol. 120 (pp. S821). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. 2009 McCarty, R. C., Gronthos, S., Zannettino, A. C., Foster, B. K., & Xian, C. J. (2009). Characterisation of ovine bone marrow derived mesenchymal stromal/stem cells and autologous application to growth plate cartilage defect. In BONE Vol. 45 (pp. S106-S107). Cambridge, ENGLAND: ELSEVIER SCIENCE INC.
DOI2009 McCarty, R. C., Gronthos, S., Zannettino, A. C., Foster, B. K., & Xian, C. J. (2009). Characterisation of ovine bone marrow derived mesenchymal stem cells and autologous application to growth plate cartilage defect. In BONE Vol. 44 (pp. S159). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI2008 Diamond, P., Labrinidis, A., Martin, S. K., Gronthos, S., To, L., Fuji, N., . . . Zannettino, A. C. W. (2008). Elevated Serum Levels of CXCL12 Is Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 23 (pp. S262). Montreal, CANADA: AMER SOC BONE & MINERAL RES. 2008 Martin, S. K., Diamond, P., To, L. B., Pect, D., Gronthos, S., & Zannettino, A. W. W. (2008). CXCL12 Expression Is Regulated by HIF-2a in Multiple Myeloma Plasma Cells. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 23 (pp. S262). Montreal, CANADA: AMER SOC BONE & MINERAL RES. 2008 Diamond, P., Labrinidis, A., Martin, S. K., Farrugia, A., Gronthos, S., To, L. B., . . . Zannettino, A. (2008). CXCL12 stimulates osteoclastic bone resorption in a novel mouse model of human multiple myeloma. In Journal of Bone and Mineral Research Vol. 23 (pp. S262). Montreal: American Society for Bone and Mineral Research. 2007 Martin, S. K., Dewar, A., Farrugia, A., Horvath, N., Gronthos, S., To, L. B., & Zannettino, A. (2007). Tumour angiogenesis is associated with plasma levels of stromal-derived factor-1a in patients with multiple myeloma. In Haematologica Vol. 92 (pp. 125-126). Kos, Greece: Ferrata Storti Foundation. 2007 See, F., Seki, T., Psaltis, P., Martens, T., Gronthos, S., Worthley, S., . . . Itescu, S. (2007). Human stroll mesenchymal precursor cells induce proliferative effects on vascular smooth muscle cells and endothelium via P13 kinase dependent pathways. In CIRCULATION Vol. 116 (pp. 104). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. 2007 Arthur, A., Koblar, S., & Gronthos, S. (2007). The role of EphB/ephrin-B interactions in cell attachment and spreading of mesenchymal precursors derived from human bone marrow and dental pulp tissues. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 22 (pp. S370-S371). Honolulu, HI: AMER SOC BONE & MINERAL RES. 2007 Diamond, P., Labrinidis, A., Martin, S. K., Farrugia, A. N., Gronthos, S., To, L. B., . . . Zannettino, A. C. W. (2007). CXCL12 stimulates osteoclastic bone resorption in a novel mouse model of human multiple myeloma. In HAEMATOLOGICA-THE HEMATOLOGY JOURNAL Vol. 92 (pp. 130). Kos Isl, GREECE: FERRATA STORTI FOUNDATION. 2007 Martin, S. K., Dewar, A. L., Farrugia, A. N., Horvath, N., Gronthos, S., To, L. B., & Zannettino, A. C. W. (2007). Tumour angiogenesis correlates with plasma levels of CXCL12 in patients with multiple myeloma. In HAEMATOLOGICA-THE HEMATOLOGY JOURNAL Vol. 92 (pp. 125-126). Kos Isl, GREECE: FERRATA STORTI FOUNDATION. 2005 Miura, Y., Gao, Z. G., Miura, M., Seo, B. M., Sonoyama, W., Chen, W. J., . . . Shi, S. T. (2005). Culture-expanded human bone marrow stromal stem cells organize functional bone marrow niches in vivo.. In BLOOD Vol. 106 (pp. 651A). Atlanta, GA: AMER SOC HEMATOLOGY. 2005 Zannettino, A., Kortesidis, A., Farrugi, A., & Gronthos, S. (2005). The role of stromal derived factor-1 alpha in bone remodelling.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 20 (pp. S368). Nashville, TN: AMER SOC BONE & MINERAL RES. 2005 McCarty, R. C., Gronthos, S., Foster, B. K., & Xian, C. J. (2005). Development of a mesenchymal stem cell based therapy for repair of growth plate cartilage in an ovine model. In BONE Vol. 36 (pp. S174). Geneva, SWITZERLAND: ELSEVIER SCIENCE INC. 2004 Martens, T. P., Schuster, M. D., See, F., Xydas, S., Hefti, M. M., Gronthos, S., . . . Itescu, S. (2004). Human mesenchymal precursors induce myocardial arteriogenesis and global functional recovery after myocardial ischemia. In CIRCULATION Vol. 110 (pp. 70). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS. 2003 Miura, M., Chen, X., Gronthos, S., Bi, Y., Allen, M. R., Lakhani, S., . . . Shi, S. (2003). Caspase-3 deficiency causes osteopenia by attenuating differentiation of osteoblast progenitors.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 18 (pp. S47). MINNEAPOLIS, MINNESOTA: AMER SOC BONE & MINERAL RES. 2003 Kostakis, P., Atkins, G., Pan, B., Farrugia, A., Gronthos, S., Evdokiou, A., . . . Zannettino, A. (2003). The relationship between RANKL expression and osteoblast differentiation in human osteoblasts. In 30th European Symposium on Calcified Tissues, 8-12 May 2003 Vol. Italy (pp. 314-468). Rome, Italy: Springer Science and Business Media LLC.
DOI2002 Gronthos, S., Chen, S., Wang, C. Y., Robey, P. G., & Shi, S. (2002). Telomerase accelerates osteogenesis of bone marrow StromalStem cells by increasing proliferation and by up-regulation of CBFA1, osterix, and osteocalcin. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 17 (pp. S196). SAN ANTONIO, TEXAS: AMER SOC BONE & MINERAL RES.
WoS12002 Shi, S., Bianco, P., Robey, P. G., & Gronthos, S. (2002). Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 17 (pp. S446). SAN ANTONIO, TEXAS: AMER SOC BONE & MINERAL RES. 2001 Stewart, K., & Beresford, J. N. (2001). A comparison of STRO-1, HOP-26, CD166 and CD49A as developmental markers for human cells of the osteogenic lineage. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 16 (pp. 1183). AMER SOC BONE & MINERAL RES.
WoS1 -
Conference Items
Year Citation 2022 Doig, R. O., Jenkner, S., Grose, R., Lewis, M., Clark, J., & Gronthos, S. (2022). SPINAL CORD INJURY-DERIVED MONOCYTES ALTER THE VIABILITY AND IMMUNOMODULATORY PHENOTYPE OF NEURAL CREST-DERIVED DENTAL PULP STEM. Poster session presented at the meeting of JOURNAL OF NEUROTRAUMA. Berlin, GERMANY: MARY ANN LIEBERT, INC. 2022 Jenkner, S., Clark, J., Gronthos, S., Grose, R., Lewis, M., & Doig, R. O. (2022). EXPERIMENTAL SPINAL CORD INJURY REVEALS NOVEL HETEROGENIC MONOCYTE SUBPOPULATIONS IN PERIPHERAL BLOOD. Poster session presented at the meeting of JOURNAL OF NEUROTRAUMA. Berlin, GERMANY: MARY ANN LIEBERT, INC. 2019 Kutyna, M. M., Wee, A., Paton, S., Cakouros, D., Arthur, A., Chhetri, R., . . . Hiwase, D. K. (2019). Aberrant Bone Marrow Microenvironment in Therapy Related Myeloid Neoplasm (t-MN). Poster session presented at the meeting of BLOOD. Orlando, FL: AMER SOC HEMATOLOGY.
DOI WoS22018 Cakouros, D., Hemming, S., Pribadi, C., Zannettino, A., & Gronthos, S. (2018). EPIGENETIC ENZYMES AND THEIR EMERGING ROLE IN MESENCHYMAL STEM CELL LINEAGE DETERMINATION. Poster session presented at the meeting of JOURNAL OF GENE MEDICINE. Univ Technol Sydney, Sydney, AUSTRALIA: WILEY. 2016 Sivanathan, K., Rojas-Canales, D., Gronthos, S., Grey, S., & Coates, P. (2016). IL-17A Preactivated Mesenchymal Stem Cells (MSC-17) Are Enriched for Genes Involved in T Cell Chemotaxis to Mediate Superior Immunosuppression.. Poster session presented at the meeting of AMERICAN JOURNAL OF TRANSPLANTATION. Boston, MA: WILEY-BLACKWELL. 2015 Kusuma, G., Menicanin, D., Gronthos, S., Abumaree, M., Brennecke, S., & Kalionis, B. (2015). MESENCHYMAL STEM CELTS DERIVED FROM HUMAN TERM, FETAL CHORIONIC VILLI AND THE MATERNAL DECIDUA PRODUCE ECTOPIC BONE <i>IN VIVO</i>. Poster session presented at the meeting of PLACENTA. W B SAUNDERS CO LTD.
DOI2015 Freeman, B., Kuliwaba, J., Zarrinkalam, M., Jones, C., Shu, C., Colloca, C., . . . Howell, S. (2015). ALLOGENEIC MESENCHYMAL STEM CELLS IMPROVE INDICES OF LUMBAR INTERVERTEBRAL DISC DEGENERATION WITHOUT SITE SPECIFICITY OF INJECTION IN AN OVINE MODEL. Poster session presented at the meeting of OSTEOARTHRITIS AND CARTILAGE. Seattle, WA: ELSEVIER SCI LTD.
DOI WoS12015 Koblar, S., Gronthos, S., & Shi, S. (2015). Stem cell therapy in stroke - human dental pulp stem cells from basic science to a clinical trial. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF STROKE. WILEY-BLACKWELL. 2014 Sivanathan, K., Hope, C., Rojas-Canales, D., Carroll, R., Gronthos, S., & Coates, P. (2014). Interferon-gamma and Interleukin-17 Modified Mesenchymal Stem Cells (MSC) Directly or Indirectly Modulate T Cell Responses By Expressing Inhibitory Factors, Downregulating T Cell Activation and Inducing Regulatory T Cells. Poster session presented at the meeting of AMERICAN JOURNAL OF TRANSPLANTATION. San Francisco, CA: WILEY-BLACKWELL. 2014 Sivanathan, K., Hope, C., Rojas-Canales, D., Carroll, R., Gronthos, S., & Coates, P. (2014). Interferon-gamma and Interleukin-17 Modified Mesenchymal Stem Cells (MSC) Directly or Indirectly Modulate T Cell Responses By Expressing Inhibitory Factors, Downregulating T Cell Activation and Inducing Regulatory T Cells.. Poster session presented at the meeting of TRANSPLANTATION. San Francisco, CA: LIPPINCOTT WILLIAMS & WILKINS.
DOI2013 Thao, N., Gronthos, S., Arthur, A., & Hayball, J. (2013). Ephb and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells. Poster session presented at the meeting of Abstracts of the Ephb and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells, as published in Experimental Hematology. Vienna, AUSTRIA: Elsevier.
DOI2012 Kusuma, G., Qin, S., Abumaree, M., Isenmann, S., Gronthos, S., Dimitriadis, E., . . . Kalionis, B. (2012). CHARACTERIZATION OF MESENCHYMAL STEM CELL LINES FROM THE HUMAN PLACENTA AND DECIDUA BY MEASUREMENT OF THE NOVEL STEMNESS MARKER, ALDEHYDE DEHYDROGENASE (ALDH). Poster session presented at the meeting of PLACENTA. Hiroshima, JAPAN: W B SAUNDERS CO LTD. 2012 Frith, J. E., Menzies, D. J., Cameron, A. R., Gronthos, S., Zannettino, A. C. W., Ghosh, P., & Cooper-White, J. J. (2012). A novel injectable hydrogel for intervertebral disc regeneration. Poster session presented at the meeting of JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE. WILEY-BLACKWELL. -
Theses
Year Citation 2016 Sivanathan, K. N. (2016). Interleukin-17A induced human mesenchymal stem cells are superior modulators of immunological function. (PhD Thesis, University of Adelaide).
National Health & Medical Research Council, Project Grant # APP1141361 (AUD $850,228.50) 2018-2021. Title: Deregulation of DNA hydroxymethylases Tet1 and Tet2 compromises skeletal integrity during ageing and osteoporosis. Chief Investigators: Stan Gronthos, Tuan Nguyen, Melissa Davis.
National Health & Medical Research Council, Project Grant # APP1142954 (AUD $548,854) 2018-2020. Title: Histone Demethylase KDM6A is a novel target for treating craniosynostosis in children with Saethre-Chotzen Syndrome. Chief Investigators: Stan Gronthos, Peter Anderson.
National Health & Medical Research Council, Project Grant # APP1120989 (AUD$562,863) 2017-2019. Title: Tyrosine kinase receptor c-ros-oncogene 1 mediates Twist-1 haploinsufficiency induced craniosynostosis in children: A novel therapeutic target. Chief investigators: Stan Gronthos, Andrew Zannettino and Peter Anderson.
National Health & Medical Research Council, Principal Research Fellowship # APP1042677 (AUD $714,745) 2013-2017. Title: Mesenchymal stem cells in bone regeneration and repair. Principal Investigator: Stan Gronthos.
National Health & Medical Research Council, Project Grant # APP1099283 (AUD $561,956) 2016-2018. Title: Osteochondroreticular stem cell therapy for osteoarthritis: right cells for the job. Chief Investigators: Dan Worthley, Stan Gronthos, Siddhartha Mukherjee, Francis Lee.
National Health & Medical Research Council, Project Grant # APP1083704 (AUD$548,347) 2015-2017. Title: The role of ephrinB1 reverse signalling in osteogenic differentiation during skeletal development and osteoporosis. Chief investigators: Stan Gronthos, Agnes Arthur and Andrew Zannettino.
Channel 7 Children’s Research Foundation Grant ($75,000) 2015. Identification of Twist-1 regulated microRNAs which control cranial bone development in Children. Principal Investigators: S. Gronthos, Esther Camp-Dotlic, Peter Anderson.
Australian Dental Research Fund #44-2014 ($11,363) 2015. The role of EphB/ephrinB activation in allogeneic Dental Pulp Stem Cell mediated dental tissue regeneration following tooth injury. Chief investigators: Stan Gronthos, Agnes Arthur.
National Health & Medical Research Council, Project Grant # APP1046053 (AUD$466,044.64) 2013-2015. Title: Twist-1 inhibits MSC osteoblast differentiation during osteoporosis via direct regulation of the Wnt signalling pathway. Chief investigators: Stan Gronthos and Andrew Zannettino.
National Health & Medical Research Council, Project Grant # APP1043994 (AUD$802,470.63) 2013-2015. Title: Comparison of periodontal ligament stem cells and induced pluripotent periodontal ligament stem cells for periodontal regeneration. Chief investigators: Mark Bartold, Stan Gronthos, Saso Ivanovski, Dietmar Hutmacher.
National Health & Medical Research Council, Project Grant #APP1023390 (AUD $591,010) 2012-2014. Title: Mesenchymal Stem Cell maintenance and recruitment during skeletal repair are dependent on EphB-ephrinB signalling. Principal Investigators: S. Gronthos, A.C.W. Zannettino.
National Health & Medical Research Council, Project Grant #APP1030528 (AUD$543,675) 2012-2014. Title: The Role of Raptor and Rictor Signalling Pathways in Osteogenesis and Mesenchymal Stem Cell Fate Determination Investigator(s): Zannettino A, Gronthos S, Fitter S.
Adelaide Research Innovation Commercialization Grant (AUD$100,000) 2014. Title: Characterisation of the molecular target of the monoclonal antibody STRO-1, in mesenchymal stem cell mediated tissue repair and immune modulation. Principal investigators: Zannettino A, Gronthos S, Fitter S.
Australian Cancer Research Foundation Infrastructure Grant ($1.8 million) 2013. South Australian Innovative Cancer Imaging and Therapeutics Facility, SAHMRI. C. Mulligan, T. Hughes, A. Zannettino, D. White, S. Gronthos, D. O’Keefe, G. Goodall, B. To, T. Monro.
Centre for Stem Cell Research, Robinson Institute, University of Adelaide Collaborative Grant ($65,000) 2013. Project: Understanding the mechanisms of aberrant bone formation in Saethre-Chotzen syndrome patients with Twist-1 mutations. Investigators: S Gronthos and A Zannettino
National Health & Medical Research Council, Senior Research Fellowship #508087(AUD $537,500) 2008-2012. Principal Investigator: Gronthos S.
National Health & Medical Research Council, Project Grant #626910 (AUD $583,500) 2010-2012 Title: Twist-1 Mediated Regulation of Multipotential Mesenchymal Stem Cell Self-Renewal and Cell Fate Determination. Principal Investigators: S. Gronthos, A.C.W. Zannettino
National Health & Medical Research Council, Project Grant #627143 (AUD $769,875) 2010-2012. Project Grant title: Generation of induced pluripotent stem (iPS) cells and their potential use in periodontal regeneration. Principal Investigators: P. M. Bartold, S.Gronthos, P. Zilm, Andrew Laslett.
National Health & Medical Research Council, Project Grant # 626911 (AUD $583,500) 2010-2012. Title: Is Hypoxia Inducible Factor-2 (HIF-2) the "Trigger" of the "Angiogenic Switch" in Multiple Myeloma? Principal Investigators: ACW Zannettino, S Gronthos, J-P Levesque, D Peet, LB To.
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2024 Co-Supervisor Capturing Molecular Regulatory Events of Haematopoietic Stem Cell Emergence From Endothelium Doctor of Philosophy Doctorate Full Time Mr Luke Bland 2023 Co-Supervisor The biological function of tryptophan metabolism in triple-negative breast cancer and cancer stem cells population Doctor of Philosophy Doctorate Full Time Mr Jamshid Motalebzadeh 2022 Principal Supervisor Identification of epigenetic factors deregulated in skeletal stem cells during high glucose medicated inhibition of bone formation Doctor of Philosophy Doctorate Part Time Mrs Suzanna Shirazi 2021 Principal Supervisor Pre-conditioning and modulation of dental pulp stem cells for the treatment of acute spinal cord injury. Doctor of Philosophy Doctorate Full Time Miss Sandra Jenkner -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2020 - 2024 Principal Supervisor Deregulation of DNA Hydroxymethylases TET1 and TET2 Compromises Skeletal Integrity During Ageing Doctor of Philosophy Doctorate Full Time Mr Nicholas John Smith 2019 - 2021 Principal Supervisor Role of Eph/ephrin Molecules in Mediating Cross-talk Between Stromal and Neural Populations in the Regulation of Neural Differentiation, Adhesion and Migration Master of Philosophy (Medical Science) Master Full Time Miss Nethmi Abeynayake 2018 - 2022 Principal Supervisor The Role of Epigenetic Modifiers, Kdm6a and Kdm6b, in Calvarial Suture Development and Craniosynostosis Doctor of Philosophy Doctorate Full Time Miss Clara Pribadi 2017 - 2022 Principal Supervisor Evaluating the Role of Bone Marrow Microenvironment in the Pathogenesis of Therapy-related Myeloid Neoplasms Doctor of Philosophy Doctorate Full Time Mrs Monika Maria Kutyna 2016 - 2019 Principal Supervisor Identification of Molecular Mechanisms Mediating TWIST-1 Regulation of Mesenchymal Stem Cell Proliferation and Differentiation Doctor of Philosophy Doctorate Full Time Mr Chee Ho H'ng 2016 - 2021 Co-Supervisor Investigating Reprogramming Factors and Neural Conditions to Convert Human Dental Pulp Stem Cells into Neural Stem Cells Doctor of Philosophy Doctorate Full Time Miss Maria Roumenova Gancheva 2012 - 2016 Principal Supervisor Epignetic Regulation of Histone Three Lysine Twenty Seven Tri Methylation Dictates Mesenchymal Stem Cell Lineage Commitment, Lifespan and Murine Skeletal Development Doctor of Philosophy Doctorate Full Time Miss Sarah Elizabeth Hemming 2012 - 2016 Co-Supervisor Interleukin-17A Induced Human Mesenchymal Stem Cells are Superior Modulators of Immunological Function Doctor of Philosophy Doctorate Full Time Dr Kisha Nandini Sivanathan 2011 - 2014 Co-Supervisor Mesenchymal Stem Cells for the Treatment of Myocardial Infarction-Induced Ventricular Dysfunction Doctor of Philosophy Doctorate Full Time Dr James David Richardson 2010 - 2015 Co-Supervisor ALPHA-L-IDURONIDASE TRANSDUCED MESENCHYMAL STEM CELLS AS A THERAPY FOR THE TREATMENT OF CNS DEGENERATION IN MUCOPOLYSACCHARIDOSIS TYPE I MICE Doctor of Philosophy Doctorate Full Time Dr Matilda Jackson 2010 - 2010 Co-Supervisor Reprogramming of Human Gingival and Periodontal Ligament Fibroblasts to Pluripotency with Defined Factors Master of Philosophy (Dentistry) Master Full Time Dr Ni-Hung Lin 2010 - 2018 Co-Supervisor The Role of mTORC1 in Mesenchymal Stem Cell Fate Determination, Osteoblast Differentiation and Skeletal Development Doctor of Philosophy Doctorate Part Time Ms Mary Patricia Matthews 2009 - 2013 Principal Supervisor The Role of TWIST-1 in the Regulation of Mesenchymal Stem Cell Growth, Fracture Repair and Bone Loss Doctor of Philosophy Doctorate Full Time Mr Lachlan Cooper 2008 - 2012 Co-Supervisor Isolation and Characterization of Stem Cell Populations in the Periodontium Doctor of Philosophy Doctorate Full Time Miss Jimin Xiong 2006 - 2010 Co-Supervisor The Cardiovascular Reparative Properties of Bone Marrow Mesenchymal Precursor Cells Doctor of Philosophy Doctorate Full Time APrf Peter Psaltis 2006 - 2010 Co-Supervisor Functional and Molecular Characterisation of Mesenchymal Stem Cells Derived from Bone Marrow and Dental Tissues Doctor of Philosophy Doctorate Full Time Dr Danijela Menicanin 2005 - 2009 Co-Supervisor Molecular and Cellular Mechanisms of Increased Angiogenesis in Multiple Myeloma: A Role for CXCL12 Doctor of Philosophy Doctorate Full Time Dr Sally Martin 2003 - 2007 Co-Supervisor Guidance and Neuronal Properties of Dental Pulp Stem Cells Doctor of Philosophy Doctorate Full Time Dr Agnes Arthur 2002 - 2008 Co-Supervisor Ovine Bone Marrow Mesenchymal Stem Cells: Isolation, Characterisation, and Developmental Potential for Application in Growth Plate Cartilage Regeneration Doctor of Philosophy Doctorate Full Time Miss Rosa Mc Carty
Connect With Me
External Profiles
